Leadership

Board of Directors

Image
maria rieders
Maria Rieders

Chairwoman, Board of Directors

Image
frank mccaney
Frank McCaney

Director, Board of Directors

Image
michael f rieders
Michael F. Rieders

Treasurer and Director, Board of Directors

Image
pierre g cassigneul
Pierre G. Cassigneul

Director, Board of Directors

Image
eric f rieders
Eric F. Rieders

Corporate Secretary, Board of Directors

Image
nick rieders
Nick Rieders

Director, Board of Directors

Image
neal mccarthy
Neal McCarthy

Director, Board of Directors

Executive Management

Image
david delia
David Delia

Chief Financial Officer

Image
marianne jackson
Marianne Jackson

Senior Vice President and General Manager, Clinical Business Unit

Image
daniel reed
Daniel Reed

Senior Vice President and General Manager, Forensic Business Unit

Image
barry logan
Barry K. Logan

Senior Vice President of Forensic Sciences and Chief Scientist

Image
robert a middleberg
Robert A. Middleberg

Senior Vice President of Quality Assurance and Regulatory Affairs; Core Laboratory Director, and Forensic Toxicologist

Image
jennifer charlton
Jennifer Charlton

Senior Vice President of Human Resources

Image
keith hoerth
Keith Hoerth

Vice President of Laboratory Operations

Maria Rieders

Chairwoman, Board of Directors

Dr. Maria Rieders joined the Board of Directors of NMS Labs in 2013. She holds an adjunct full professor position at the Wharton School at the University of Pennsylvania where she teaches courses on stochastic processes, queueing theory and operations management. Dr. Maria Rieders holds a M.Sc. degree in applied mathematics from the Universitat Ulm, Germany and a Ph.D. in business administration from the University of Rochester. Previous employments include a scientific staff position at the Allensbach Institute for Public Opinion Research in Allensbach, Germany, a faculty position at the Department of Industrial Engineering and Management Sciences at Northwestern University, and a visiting researcher post at the Institute for Operations Research at the Universität Bonn, Germany. Her research focuses on designing and analyzing stochastic models and has been funded by the National Science Foundation, by Ameritech Corporation, and, through collaboration with students, by Motorola and Argonne National Laboratory.

Back to the Top


Michael F. Rieders

Treasurer and Director, Board of Directors

Dr. Rieders was Laboratory Director, President and CEO from 1988 – 2008 and Interim CEO from January to July, 2020. He was Chairman of the Board of Directors from 2001-2013.

Dr. Rieders is a Forensic Toxicologist and Fellow of The American Academy of Forensic Sciences (AAFS) where he Chaired the AAFS Opioids and Emerging Drugs ad hoc Committee. He is also a member of the Society of Forensic Toxicologists (SOFT), The International Association of Forensic Toxicologists (TIAFT), the World Association of Medical Law (WAML), and The National Association of Medical Examiners (NAME) and NAME Foundation Board of Trustees.

Dr. Rieders earned a Chemistry degree from Arcadia University (formerly Beaver College) in 1980, and a PhD in Pharmacology/Toxicology from Thomas Jefferson University in 1985. He is past President of the Jefferson College of Graduate Studies Alumni Association; he was honored as Distinguished Alumnus and was the 2015 honoree of the Jefferson President's Award and Jefferson's Leader of Innovation Medal in May of 2021.

Dr. Rieders is Commissioner and Chief Science Officer of The Vidocq Society.

Back to the Top


Eric F. Rieders

Corporate Secretary, Board of Directors & Interim CEO

Dr. Rieders earned a Doctorate in Mathematics from Syracuse University and a BS in Chemistry and Mathematics from Ripon College (Ripon, WI). He is also the Chairman of the Board of the Fredric Rieders Family Renaissance Foundation and an adjunct Professor of Forensic Science at Arcadia University.

Back to the Top


Frank McCaney

Director, Board of Directors

Frank McCaney is the Chairman of the Board of Directors at NMS Labs. He is an accomplished executive with more than 25 years of demonstrated growth and success in medical devices and drug development. Experienced in Business Management at the CEO level, drug development, raising capital, M&A, Sales and Marketing, and turnarounds. Mr. McCaney previously served as CEO of Strata Skin Sciences (SSKN: NASDAQ) and before that he was CEO of Corpak MedSystems, a private equity-backed medical device company in the field of enteral feeding. Corpak was sold to Halyard Health (HYH: NYSE) for $174 million in May 2016. Prior to Corpak, he was the founder and CEO of Nitric BioTherapeutics, a venture backed-medical technology company from 2006 until 2012. Prior to Nitric Bio, he was a senior executive at Viasys Healthcare, Inc. (VAS: NYSE), a medical technology company focusing on respiratory, neurology, medical disposable and orthopedic products and had a lead role in spinning Viasys out of Thermo Electron Corporation (TMO: NYSE). While at Viasys, Mr. McCaney had several responsibilities including strategy, business development and investor relations. He currently serves as a director of Diasome Pharmaceuticals, a privately-held company. Frank is also the Chairman of the Board of Allevi Inc, a Tissue Bioprinting company located in Philadelphia.

Back to the Top


Pierre G. Cassigneul

Director, Board of Directors

Mr. Cassigneul has over 30 years’ experience leading organizations and high-growth-potential start-ups through the development and launch of innovative tests and high-science clinical diagnostic solutions. He has led NMS labs as President and CEO for 6 years before retiring in Dec 2019. Previously, he was with Predictive Biosciences as President and CEO. Mr. Cassigneul was born in France where he graduated from Reims Management School.

Back to the Top


Nick Rieders

Director, Board of Directors

Nicholas F. Rieders, BSRN, CCTM has been employed as a registered nurse at Jefferson University Hospital for 6 years in the Intermediate Neurological Intensive Care and Comprehensive Spine Units. Nicholas earned a Bachelor of Science in Kinesiology from Temple University and went on to complete an accelerated bachelors degree in Nursing at Villanova University where he was inducted into the nursing honors society, Sigma Theta Tau.

Nicholas is passionate about making a difference through compassionate and individualized care and continues to seek out new learning and leadership opportunities.

Nicholas has served on the Board of Directors for the Fredric Rieders Family Renaissance Foundation and is honored to join the Board of Directors of NMS Labs to continue the legacy of Dr. Fredric Rieders.

Back to the Top


Neal McCarthy

Director, Board of Directors

Cornelius P. McCarthy is a founding partner and Managing Director of Fairmount Partners, a Philadelphia based investment bank. Neal focuses primarily on the healthcare and laboratory sciences sectors, and has assisted clients to complete financings, acquisitions, mergers and divestitures throughout North and South America, Europe, Asia and Australia. Prior to founding the Company, Neal was the US Head of Corporate Finance and Head of Healthcare Investment Banking at Investec, Inc., an international banking group based in the UK. 

Before joining Investec, Neal worked for investment banks in New York and Los Angeles where he specialized in mergers and acquisitions and public offerings of equity and debt. He has significant experience in healthcare, cable and telecommunications, insurance, manufacturing, and transportation. Before that he practiced securities and general corporate law for the firm of Gibbons PC. 

He previously served on the Board of Phoenix International Life Sciences, a large public pharmaceutical research and labs business, and the Board of Medpace Inc. a top 10 clinical CRO, assisting both with strategy and acquisitions. He is a member of the Drug Information Association and the American Association of Pharmaceutical Scientists. 

Neal received his legal degree from Villanova University School of Law and earned his undergraduate degree from the University of Virginia, where he was an Echols Scholar.

Back to the Top


David Delia

David Delia is Chief Financial Officer at NMS Labs. David is responsible for NMS Labs’ financial management and information technology, including business planning and program management. Additionally, he oversees the facilities and purchasing for the company and is a member of the executive management team. 

David has extensive operational and financial experience in healthcare and was named Chief Financial Officer in 2016 after serving as Senior Vice President of Operations at Alliance Health Care Services for 4 years. Prior to that, David spent 12 years in financial and operations roles at LabCorp, the largest clinical laboratory in the United States.

David holds a Master of Business Administration from the University of South Florida and a Bachelor of Science from East Carolina University.

Back to the Top


Marianne Jackson

Marianne Jackson is the Senior Vice President and General Manager for the Clinical Business Unit at NMS Labs. She joined the company in April of 2021 and is responsible for overseeing the strategic growth and expansion of the clinical business.

Marianne has an extensive commercial background with over 25 years of experience with life science companies. She has worked in large, mid-size and start-up biopharma companies, building and leading functional areas in marketing, market access, sales and commercial operations. Most recently, Marianne worked as the Senior Vice President of Sales and Market Access at Synergy Pharmaceuticals. Prior to that she served as the SVP of Global Commercial Operations at Shire, helping transform the organization into a rare disease company that was acquired by Takeda. Earlier in her career Marianne worked in a variety of commercial roles in AstraZeneca and Merck.

Marianne holds a Master of Science and Bachelor of Business Administration from Texas A&M University.

Back to the Top


Daniel Reed

Daniel Reed is the Senior Vice President and General Manager for the Forensic Business Unit at NMS Labs.  Dan joined the team in August of 2021, and is responsible for overseeing the strategic growth and expansion of the forensic business.

With over a decade of experience in market intelligence and research, strategy, portfolio management, pricing, and supply chain, Dan has led teams focused on order management, contract management, and sales CRM and quoting tools.  Most recently, he served as the Senior Director of Global Commercial Operations for the Chromatography and Mass Spectrometry Division of Thermo Fisher.  Additionally, Dan was previously an economist at the Bureau of Economic Analysis.

Dan holds a Masters in Business Administration with Distinction from the Tuck School of Business at Dartmouth and a Bachelor of Arts in Economics and History from the University of Virginia.

Back to the Top


Barry K. Logan

Dr. Barry Logan is Sr. V/P of Forensic Sciences, and Chief Scientist at NMS Labs. He joined NMS Labs in 2008. He is also Executive Director at the non-profit Center for Forensic Science Research and Education (CFSRE) at the Fredric Rieders Family Foundation in Willow Grove, Pennsylvania. At NMS Labs he leads our team of forensic toxicologists and certifying scientists and is the laboratory director for NMS Criminalistics Laboratories in Pennsylvania, Texas and North Carolina.

Dr. Logan is a Fellow of the American Board of Forensic Toxicologists (ABFT), and has over 150 publications and over 600 presentations in forensic toxicology and analytical chemistry, including work on the effects of illicit and prescription drugs on drivers, and drug caused and related death. His current research priorities are focused on new drug trends, the opioid crisis, rapid reporting of drug mortality data, and the analytical and interpretive toxicology and chemistry of novel psychoactive substances, founding www.NPSDiscovery.org in 2018.

Dr. Logan’s other appointments include Executive Director of the Robert F. Borkenstein course at Indiana University, and at Arcadia University and Thomas Jefferson University in Philadelphia. He serves on the Advisory Board for NIDA’s National Drug Early Warning System (NDEWS). In recognition of his work and contributions, Dr. Logan has received numerous national and international awards, and served as President of the American Academy of Forensic Sciences (AAFS) in 2013-14.

Back to the Top


Robert A. Middleberg

Dr. Robert A. Middleberg is the Core Laboratory Director and Sr. Vice President of Quality Assurance and Regulatory Affairs at NMS Labs. He earned his Ph.D. in Pharmacology from Thomas Jefferson University and a Master’s Degree in Chemistry from the University of Pittsburgh. He is a Fellow of the American Board of Forensic Toxicology (F-ABFT) and a Diplomate in Toxicological Chemistry from the American Board of Clinical Chemistry (DABCC-TC). Dr. Middleberg is a faculty member at Thomas Jefferson University. He holds a position on the Board of Directors for the American Board of Forensic Toxicology and served previously as a Director on the American Board of Clinical Chemistry. Dr. Middleberg was awarded the Rolla N. Harger award in 2013 for contributions to forensic toxicology by the Toxicology Section of the American Academy of Forensic Sciences. He is a member of many professional organizations, including the American Academy of Forensic Sciences, the American Association for Clinical Chemistry and the International Association of Therapeutic Drug Monitoring and Clinical Toxicology. Dr. Middleberg was a long-standing member of the College of American Pathologists’ Toxicology Committee and now serves as an advisor and currently sits on the Editorial Board for the Journal of Forensic Sciences.

Back to the Top


Jennifer Charlton

Jennifer Charlton is the Senior Vice President of Human Resources at NMS Labs.  She joined the company in December 2019 and is responsible for leading employee engagement, compensation and benefits, talent acquisition, training and development, HR operations and employee relations.  Additionally, Jen is a member of the executive management team.

Jen has extensive HR and business support experience in the banking and transportation industries.  She spent 23 years at Bank of America in senior HR roles supporting global wealth and retirement, commercial real estate and credit card businesses, and most recently spent 5 years in a senior HR role supporting the Commercial Executive, Chief Marketing Officer and Chief Financial Officer of Amtrak. 

Jen holds a Master of Business Administration and a Bachelor of Science from the University of Delaware. 

Back to the Top


Keith Hoerth

Keith Hoerth is the Vice President of Laboratory Operations at NMS Labs. He is responsible for the Core Laboratory Operations of NMS Labs with a focus on meeting the expectations of the clients, goals of the organization, and stringent national accreditation requirements.

Keith has nearly 20 years of laboratory experience starting as a laboratory scientist and continuing to progress in his career. Most recently he was Vice President of Laboratory Services at Kaleida Health, a large health care system in Buffalo, NY. Prior to that role, Mr. Hoerth was the Director of Laboratory Services for SwedishAmerican Health system, part of UW Health, in Rockford, IL.  He has been a lead inspector for the College of American Pathologists, and American Association of Blood Banks assessment teams with a focus on driving continual quality and process improvement. 

Keith obtained his Fellowship in the American College of Healthcare Executives, holds an MHA from the University of Phoenix, Bachelor of Science in Clinical Laboratory Science from the University of Wisconsin, and is a certified Medical Laboratory Scientist. 

Back to the Top